IMVT Immunovant
- 29.760
- +0.180+0.61%
- 29.760
- 0.0000.00%
Immunovant News
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Stout Jay S
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Geffner Michael
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Levine Mark S.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Levine Mark S.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Macias William L.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Barnett Eva Renee
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Butchko Julia G.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Salzmann Peter
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Barnett Eva Renee
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Butchko Julia G.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Salzmann Peter
Immunovant | 4: Statement of changes in beneficial ownership of securities-Director Fromkin Andrew J.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Director Hughes Douglas J.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Director MIGAUSKY GEORGE V
Immunovant | 4: Statement of changes in beneficial ownership of securities-Director Torti Frank
Immunovant | 4: Statement of changes in beneficial ownership of securities-Director Pande Atul
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Stout Jay S
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Levine Mark S.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Macias William L.
Immunovant | 4: Statement of changes in beneficial ownership of securities-Officer Geffner Michael
Analysis
Price Target
No Data
